AJP - Renal Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Renal Physiol 265: F592-F597, 1993;
0363-6127/93 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dai, L. J.
Right arrow Articles by Quamme, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dai, L. J.
Right arrow Articles by Quamme, G. A.

AJP - Renal Physiology, Vol 265, Issue 4 592-F597, Copyright © 1993 by American Physiological Society

ARTICLES

Atrial natriuretic peptide initiates Ca2+ transients in isolated renal cortical thick ascending limb cells

L. J. Dai and G. A. Quamme
Department of Medicine, University of British Columbia, University Hospital, Vancouver, Canada.

The following studies identified and characterized atrial natriuretic peptide (ANP) receptor-mediated Ca2+ transient in cortical thick ascending limb (CTAL) cells. Primary cell cultures were prepared from porcine kidneys by immunodissection, and intracellular Ca2+ concentration ([Ca2+]i) was determined in single cells with microfluorometry. ANP (10(-7) M) and its analogue, C-type natriuretic peptide (CNP, 10(-7) M), elicited Ca2+ transients [104 +/- 6 (basal levels) to 653 +/- 112 nM (stimulated) and from 84 +/- 4 to 209 +/- 18 nM, respectively]. Receptor-mediated [Ca2+]i increase was dose-dependent with a 50% effective concentration (EC50) of approximately 10(-10) M. The increment in [Ca2+]i was due to internal release and influx across the plasma membrane. Prior treatment of ANP or CNP (10(-7)M) did not markedly affect a post application of either ANP or CNP. The truncated analogue of ANP, C-ANP-(4-23), which preferentially binds to clearance receptors, elicited an increase in [Ca2+]i (82 +/- 1 to 427 +/- 41 nM). 8-Bromoguanosine 3',5'-cyclic monophosphate (8-BrcGMP) did not alter [Ca2+]i, but pretreatment of CTAL cells with 8-BrcGMP for 30 min before agonist treatment prevented ANP-induced Ca2+ signals [83 +/- 5 (basal) to 88 +/- 5 nM (stimulated)]. These results are evidence for the existence of clearance ANP receptors in CTAL cells that may have biological functions and clearance. The functional responses of these signal interactions may have important consequences on hormone actions with the CTAL.


This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
T. Chitapanarux, S. L. Chen, H. Lee, A. C. Melton, and H. F. Yee Jr.
C-type natriuretic peptide induces human colonic myofibroblast relaxation
Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G31 - G36.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
K. S. Murthy and G. M. Makhlouf
Identification of the G Protein-activating Domain of the Natriuretic Peptide Clearance Receptor (NPR-C)
J. Biol. Chem., June 18, 1999; 274(25): 17587 - 17592.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
S. Kanwal, B. J. Elmquist, and G. J. Trachte
Atrial Natriuretic Peptide Inhibits Evoked Catecholamine Release by Altering Sensitivity to Calcium
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 426 - 433.
[Abstract] [Full Text]

Home page
 HypertensionHome page
M. Nagase, K. Ando, T. Katafuchi, A. Kato, S. Hirose, and T. Fujita
Role of Natriuretic Peptide Receptor Type C in Dahl Salt-Sensitive Hypertensive Rats
Hypertension, August 1, 1997; 30(2): 177 - 183.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online